These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17902729)

  • 21. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
    Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
    Meltzer EO; Gillman SA
    Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic options in idiopathic chronic urticaria].
    Mora PM; González Pérez Mdel C; Jiménez Villarruel M; Rodriguez Castro E; Fogelbach GG
    Rev Alerg Mex; 2005; 52(2):77-82. PubMed ID: 16158780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
    Grob JJ; Lachapelle JM
    Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
    Belsito DV
    J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desloratadine: a nonsedating antihistamine.
    Limon L; Kockler DR
    Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desloratadine: A new, nonsedating, oral antihistamine.
    Geha RS; Meltzer EO
    J Allergy Clin Immunol; 2001 Apr; 107(4):751-62. PubMed ID: 11295678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desloratadine in the treatment of chronic idiopathic urticaria.
    Ring J; Hein R; Gauger A
    Allergy; 2001; 56 Suppl 65():28-32. PubMed ID: 11243502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
    Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of H1 antihistamines in the treatment of chronic idiopathic urticaria.
    Monroe E
    Cutis; 2005 Aug; 76(2):118-26. PubMed ID: 16209158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.
    Levi A; Enk CD
    Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):302-6. PubMed ID: 26052871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
    Grob JJ; Auquier P; Dreyfus I; Ortonne JP
    Allergy; 2009 Apr; 64(4):605-12. PubMed ID: 19133920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
    J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
    Cassano N; Raho G; Filieri M; D'Argento V; Amoruso A; Filotico R; Vena GA
    Int J Dermatol; 2006 Apr; 45(4):394-6. PubMed ID: 16650165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K; Jarvis B
    Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
    Hong JB; Lee HC; Hu FC; Chu CY
    J Am Acad Dermatol; 2010 Nov; 63(5):e100-2. PubMed ID: 20950731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.